sharecast

{{ storiesRelated.title }}

Full List Of Stories
19 Feb
land securities, bluewater
Spaceandpeople signs new extended agreement with Landsec

SpaceandPeople announced a contract renewal, as well as a significant expansion of opportunities with Landsec in the UK on Monday.

19 Feb
Money cash dollars
Next 15 trades in line, expects some US tax reform benefits

Digital communications group Next 15 updated the market on its trading on Monday, ahead of its results for the year to 31 January, which are due to be announced in early April.

19 Feb
car-tyres-63928_1920-300x200
Directa Plus gets Italian patent for tyre applications

Graphene-based products producer and supplier Directa Plus announced on Monday that the Ufficio Brevetti e Marchi - the Italian patent and trademark office- has granted it a patent for the product and application of its new graphene-based solution for enhancing the performance of tyres.

19 Feb
20141030 122019 opt 1 opt
Kin shares to be suspended as it hunts for reverse takeover offers

Kin Group updated the market on its states as a cash shell under rule 15 of the AIM rules on Monday - a status it entered into on 30 August last year, when its principal trading subsidiary appointed administrators.

19 Feb
Astrazeneca
Diurnal finds partner to break Australia and New Zealand markets

Specialty pharmaceutical company Diurnal Group announced a marketing and distribution agreement with specialised Australian pharmaceutical firm Emerge Health on Monday.

19 Feb
calculatrice et trombones comptes entrepreneurs entreprises argent finances tpe pme entreprenariat finances banques startup business plan argent
MedaPhor launches new lifelike ultrasound simulation trainer

Ultrasound software and simulation company MedaPhor Group announced the launch of its new BodyWorks Eve simulator platform on Monday, which it described as an ultra-realistic manikin-based simulator to train medical professionals practising point-of-care ultrasound (PoCUS) across emergency medicine and critical care.

19 Feb
coins currency investment insurance business finance company
Unexpected delay arises in Quadrise boiler trial project

Quadrise Fuels International updated the market on its planned combustion boiler trial project in the Kingdom of Saudi Arabia on Monday.

19 Feb
calculatrice et trombones comptes entrepreneurs entreprises argent finances tpe pme entreprenariat finances banques startup business plan argent
Hardide trading in line ahead of first half results

Investors in Hardide were told of how the company was continuing to trade in line with expectations at its annual general meeting on Monday.

19 Feb
ep logo toyota 20180104132201
Asia report: Markets mostly higher as China remains closed

Markets in Asia were mostly higher in a quiet session on Monday, with Greater China bourses still on holiday for the Lunar New Year.

19 Feb
libra, esterlina, divisa, moneda, reino unido pound currency
City of London Investment Group makes good first-half progress

City of London Investment Group released its half-year results for the six months to 31 December on Monday, with funds under management reaching $5. 3bn (£3. 9bn) at period end, rising from $4. 7bn at the beginning of the financial year.

19 Feb
London houses
MJ Gleeson on track to meet full-year expectations

Community regeneration housebuilder MJ Gleeson announced a “strong performance” for its first half on Monday, with profit before tax up 19. 1% and an increase in the interim dividend of 38. 5% to 9. 0p per share.

19 Feb
money euros cash
Secure Property makes solid NAV gains in 2017

South eastern European-focussed property and investment company Secure Property Development & Investment announced on Monday that, as at 31 December, the net asset value of its portfolio of properties stood at approximately €51. 5m - including €2. 8m being the net value of the prepayments already made by year-end for the Olympians project in Romania.

19 Feb
Money coins pound
Fidessa sees 'solid growth' as firms look towards new tech

Trading and investment management software and services provider Fidessa reported solid growth it its transforming markets in its final results on Monday, with revenue rising 7% to £353. 9m.

19 Feb
astrazeneca
AstraZeneca's Imfinzi clears another FDA hurdle

AstraZeneca and MedImmune, its global biologics research and development arm, announced on Monday that the US Food and Drug Administration has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy (CRT).